大葉大學圖書館 |

Cancer imaging[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.99/40754
杜威分類號:	616.99/4240754
書名/作者:	Cancer imaging/ edited by M.A. Hayat.
其他作者:	Hayat, M. A.,
出版者:	Amsterdam ; : Elsevier, Academic Press,, c2008-
面頁冊數:	v. : : ill. (some col.) ;; 29 cm.
叢書名:	Cancer imaging
標題:	Cancer - Imaging.
標題:	Diagnostic Imaging - methods.
標題:	Neoplasms - diagnosis.
標題:	Breast Neoplasms - diagnosis.
標題:	Diagnostic Imaging - instrumentation.
標題:	Lung Neoplasms - diagnosis.
ISBN:	9780123742124
ISBN:	0123742129
書目註:	Includes bibliographical references and indexes.
內容註:	V. 1: Strategies for imaging biology in cancer and other diseases -- Synthesis of p18 sF-fluoromisonidazole tracer for positron emission tomography -- Radiation hormesis -- Molecular imaging in early therapy monitoring -- Positron emission tomography in medicine: an overview -- Radiation dose and image quality -- Contrast agents for magnetic resonance imaging: an overview -- Whole-body computed tomography screening -- Whole-body p18 sF-fluorodeoxyglucose-positron emission tomography: is it valuable for health screening? -- Staging solid tumors with p18 sF-fluorodexoyglucose-positron emission tomography/computed tomography -- Laser doppler perfusion imaging: clinical diagnosis -- Dynamic sonographic tissue perfusion measurement with the pixelflux method -- Immuno-positron emission tomography -- Role of imaging biomarkers in drug development -- The role of imaging in lung cancer -- Lung cancer staging: integrated p18 sF-fluorodeoxyglucose-positron emission tomography/computed tomography and computed tomography alone -- Computed tomography screening for lung cancer -- Lung cancer: role of multislice computed tomography -- Surgically resected pleomorphic lung carcinoma: computed tomography -- Lung cancer: low dose helical computed tomography -- Lung cancer: computer-aided diagnosis with computed tomography -- Stereotactic radiotherapy for non-small lung carcinoma computed tomography -- Thin-section computed tomography correlates with clinical outcome in patients with mucin-producing adenocarcinoma of the lung -- Non-small lung carcinoma: p18 sF-fluorodeoxyglucose-positron emission tomography -- Evaluating positron emission tomography in non-small cell lung cancer: moving beyond accuracy to outcome -- Non-small cell lung cancer: false-positive results with p18 sF-fluorodeoxyglucose-positron emission tomography -- Oxygen-enhanced proton magnetic resonance imaging of the human lung -- Detection of pulmonary gene transfer using iodide-124/positron emisson tomography -- Lung cancer with idiopathic pulmonary fibrosis: high-resolution computed tomography -- Categorization of mammographic density for breast cancer: clinical significance -- Breast tumor classification and visualization with machine-learning approaches -- Mass detection scheme for digitized mammography -- Full-field digital phase-contrast mammography -- Full-field digital mammography versus film-screen mammography -- Use of contrast-enhanced magnetic resonance imaging for detecting invasive lobular carcinoma --
摘要、提要註:	With cancer related deaths projected to rise to 10.3 million people by 2020, the need to prevent, diagnose, and cure cancer is greater than ever. These two volumes present readers with the most up-to-date imaging instrumentation, general and diagnostic applications for various cancers. Both volumes discuss the various imaging techniques used to locate and diagnose tumors, including ultrasound, X-ray, color Doppler sonography, PET, CT, PET/CT, MRI, SPECT, diffusion tensor imaging, dynamic infrared imaging, and magnetic resonance spectroscopy. They also detail strategies for imaging cancer, emphasizing the importance of the use of this technology for clinical diagnosis. Imaging techniques that predict the malignant potential of cancers, response to chemotherapy and other treatments, recurrence, and prognosis are also detailed. Both volumes [Volume 1: 978-0-12-370468-9 and Volume 2: 978-0-12-374183-7] are sold separately for $189 each. Concentrates on the application of imaging technology to the diagnosis and prognosis of lung, breast, prostate, colorectal, ovarian, gastrointestinal, and bone cancers Addresses relationship between radiation dose and image quality Discusses the role of molecular imaging in identifying changes for the emergence and progression of cancer at the cellular and/or molecular levels.
電子資源:	An electronic book accessible through the World Wide Web; click for information
電子資源:	http://www.loc.gov/catdir/toc/ecip079/2007002969.html

Cancer imaging[electronic resource] /
Cancer imaging[electronic resource] /edited by M.A. Hayat. - Amsterdam ;Elsevier, Academic Press,c2008- - v. :ill. (some col.) ;29 cm. - Cancer imaging.

Includes bibliographical references and indexes.

V. 1: Strategies for imaging biology in cancer and other diseases -- Synthesis of p18 sF-fluoromisonidazole tracer for positron emission tomography -- Radiation hormesis -- Molecular imaging in early therapy monitoring -- Positron emission tomography in medicine: an overview -- Radiation dose and image quality -- Contrast agents for magnetic resonance imaging: an overview -- Whole-body computed tomography screening -- Whole-body p18 sF-fluorodeoxyglucose-positron emission tomography: is it valuable for health screening? -- Staging solid tumors with p18 sF-fluorodexoyglucose-positron emission tomography/computed tomography -- Laser doppler perfusion imaging: clinical diagnosis -- Dynamic sonographic tissue perfusion measurement with the pixelflux method -- Immuno-positron emission tomography -- Role of imaging biomarkers in drug development -- The role of imaging in lung cancer -- Lung cancer staging: integrated p18 sF-fluorodeoxyglucose-positron emission tomography/computed tomography and computed tomography alone -- Computed tomography screening for lung cancer -- Lung cancer: role of multislice computed tomography -- Surgically resected pleomorphic lung carcinoma: computed tomography -- Lung cancer: low dose helical computed tomography -- Lung cancer: computer-aided diagnosis with computed tomography -- Stereotactic radiotherapy for non-small lung carcinoma computed tomography -- Thin-section computed tomography correlates with clinical outcome in patients with mucin-producing adenocarcinoma of the lung -- Non-small lung carcinoma: p18 sF-fluorodeoxyglucose-positron emission tomography -- Evaluating positron emission tomography in non-small cell lung cancer: moving beyond accuracy to outcome -- Non-small cell lung cancer: false-positive results with p18 sF-fluorodeoxyglucose-positron emission tomography -- Oxygen-enhanced proton magnetic resonance imaging of the human lung -- Detection of pulmonary gene transfer using iodide-124/positron emisson tomography -- Lung cancer with idiopathic pulmonary fibrosis: high-resolution computed tomography -- Categorization of mammographic density for breast cancer: clinical significance -- Breast tumor classification and visualization with machine-learning approaches -- Mass detection scheme for digitized mammography -- Full-field digital phase-contrast mammography -- Full-field digital mammography versus film-screen mammography -- Use of contrast-enhanced magnetic resonance imaging for detecting invasive lobular carcinoma --

With cancer related deaths projected to rise to 10.3 million people by 2020, the need to prevent, diagnose, and cure cancer is greater than ever. These two volumes present readers with the most up-to-date imaging instrumentation, general and diagnostic applications for various cancers. Both volumes discuss the various imaging techniques used to locate and diagnose tumors, including ultrasound, X-ray, color Doppler sonography, PET, CT, PET/CT, MRI, SPECT, diffusion tensor imaging, dynamic infrared imaging, and magnetic resonance spectroscopy. They also detail strategies for imaging cancer, emphasizing the importance of the use of this technology for clinical diagnosis. Imaging techniques that predict the malignant potential of cancers, response to chemotherapy and other treatments, recurrence, and prognosis are also detailed. Both volumes [Volume 1: 978-0-12-370468-9 and Volume 2: 978-0-12-374183-7] are sold separately for $189 each. Concentrates on the application of imaging technology to the diagnosis and prognosis of lung, breast, prostate, colorectal, ovarian, gastrointestinal, and bone cancers Addresses relationship between radiation dose and image quality Discusses the role of molecular imaging in identifying changes for the emergence and progression of cancer at the cellular and/or molecular levels.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2008.

Mode of access: World Wide Web.

ISBN: 9780123742124

Source: 141839:141984Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

403967
Cancer
--Imaging.Index Terms--Genre/Form:

336502
Electronic books.

LC Class. No.: RC280.L8 / C34 2008eb

Dewey Class. No.: 616.99/40754

National Library of Medicine Call No.: QZ 241 / C2144 2008

Cancer imaging[electronic resource] /
LDR:14406cam 2200421Ia 4500 001 337662
003 OCoLC
005 20100729101520.0
006 m d
007 cr cn|||||||||
008 110620m20089999ne a ob 001 0 eng d
020 $a 9780123742124
020 $a 0123742129
029 1 $a NZ1 $b 12541693
029 1 $a AU@ $b 000043178533
035 $a (OCoLC)228148530
035 $a ocn228148530
037 $a 141839:141984 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $c OPELS $d OCLCQ
049 $a TEFA
050 1 4 $a RC280.L8 $b C34 2008eb
060 1 4 $a QZ 241 $b C2144 2008
082 0 4 $a 616.99/40754 $2 22
082 0 4 $a 616.99/4240754 $2 22
245 0 0 $a Cancer imaging $h [electronic resource] / $c edited by M.A. Hayat.
260 $a Amsterdam ; $a Boston : $b Elsevier, Academic Press, $c c2008-
300 $a v. : $b ill. (some col.) ; $c 29 cm.
440 0 $a Cancer imaging
504 $a Includes bibliographical references and indexes.
505 0 $a V. 1: Strategies for imaging biology in cancer and other diseases -- Synthesis of p18 sF-fluoromisonidazole tracer for positron emission tomography -- Radiation hormesis -- Molecular imaging in early therapy monitoring -- Positron emission tomography in medicine: an overview -- Radiation dose and image quality -- Contrast agents for magnetic resonance imaging: an overview -- Whole-body computed tomography screening -- Whole-body p18 sF-fluorodeoxyglucose-positron emission tomography: is it valuable for health screening? -- Staging solid tumors with p18 sF-fluorodexoyglucose-positron emission tomography/computed tomography -- Laser doppler perfusion imaging: clinical diagnosis -- Dynamic sonographic tissue perfusion measurement with the pixelflux method -- Immuno-positron emission tomography -- Role of imaging biomarkers in drug development -- The role of imaging in lung cancer -- Lung cancer staging: integrated p18 sF-fluorodeoxyglucose-positron emission tomography/computed tomography and computed tomography alone -- Computed tomography screening for lung cancer -- Lung cancer: role of multislice computed tomography -- Surgically resected pleomorphic lung carcinoma: computed tomography -- Lung cancer: low dose helical computed tomography -- Lung cancer: computer-aided diagnosis with computed tomography -- Stereotactic radiotherapy for non-small lung carcinoma computed tomography -- Thin-section computed tomography correlates with clinical outcome in patients with mucin-producing adenocarcinoma of the lung -- Non-small lung carcinoma: p18 sF-fluorodeoxyglucose-positron emission tomography -- Evaluating positron emission tomography in non-small cell lung cancer: moving beyond accuracy to outcome -- Non-small cell lung cancer: false-positive results with p18 sF-fluorodeoxyglucose-positron emission tomography -- Oxygen-enhanced proton magnetic resonance imaging of the human lung -- Detection of pulmonary gene transfer using iodide-124/positron emisson tomography -- Lung cancer with idiopathic pulmonary fibrosis: high-resolution computed tomography -- Categorization of mammographic density for breast cancer: clinical significance -- Breast tumor classification and visualization with machine-learning approaches -- Mass detection scheme for digitized mammography -- Full-field digital phase-contrast mammography -- Full-field digital mammography versus film-screen mammography -- Use of contrast-enhanced magnetic resonance imaging for detecting invasive lobular carcinoma --
505 0 $a Axillary lymph node status in breast cancer: pinhole collimator single-photon emission computed tomography -- Detection of small-size primary breast cancer: p99 smTc-tetrofosmin single photon emission computed tomography -- Microcalcification in breast lesion: radiography and histopathology -- Benign and malignant breast lesions: doppler sonograpy -- Response to neoadjuvant treatment in patients with locally advanced brest cancer: color-doppler ultrasound contrast medium (levovist) -- Magnetic resonance spectroscopy of breast cancer: current techniques and clinical applications -- Breast scintigraphy -- Primary breast cancer: false-negative and false-positive bone scintigraphy -- Improved sensitivity and specificity of breast cancer thermography -- Optical mammography -- Digital mammography -- Screening for breast cancer in women with a familial or genetic predisposition: magnetic resonance imaging versus mammography -- Mammographic screening: impact on survival -- False-positive mammography examinations -- Breast dose in thoracic computed tomography -- Absorbed dose measurement in mammography -- Metastatic choriocarcinoma to the breast: mammography and color doppler ultrasound -- Detection and characterization of breast lesions: color-coded signal intensity curve software for magnetic resonance-based breast imaging -- Detection of breast malignancy: different magnetic resonance imaging modalities -- Breast lesions: computerized analysis of magnetic resonance imaging -- Optical imaging techniques for breast cancer -- Magnetic resonance imaging: measurements of breast tumor volume and vascularity for monitoring response to treatment -- Defining advanced breast cancer: p18 sF-fluorodeoxyglucose-positron emission tomography -- Leiomyoma of the breast parenchyma: mammographic, sonographic, and histopathologic features -- Detection of breast cancer: dynamic infrared imaging -- Phyllodes breast tumors: magnetic resonance imaging.
505 0 $a V. 2: Proton computed tomography -- Multidetector computed tomography -- Megavoltage computed tomography imaging -- Integrated set-3000G/X positron emission tomography scanner -- High-resolution magic angle spinning magnetic resonance spectroscopy -- Spatial dependency of noise and its correlation among various imaging modalities -- Computed tomography scan methods account for respiratory motion in lung cancer -- Respiratory motion artifact using positron emission tomography/computed tomography -- Gadolinium-based contrast media used in magnetic resonance imaging: an overview -- Molecular imaging of cancer with superparamagnetic iron-oxide nanoparticles -- Adverse reactions to iodinated contrast media -- The accuracy of diagnostic radiology -- Diffraction-enhanced imaging: applications to medicine -- Role of imaging in drug development -- Characterization of multiple aspects of tumor physiology by multitracer positron emission tomography -- Whole-body magnetic resonance imaging in patients with metastases -- Whole-body imaging in oncology: positron emission tomography/computed tomography (PET/CT) -- Whole-body cancer imaging: simple image fusion with positron emission tomography/computed tomography -- Whole body tumor imaging: O-[ p11 sC]methyl-L-tyrosine/positron emission tomography -- Tumor proliferation 2-[ p11 sC]-thymidine positron emission tomography -- p18 sF-fluorodeoxyglucose-positron emission tomography in oncology: advantages and limitations -- Positron emission tomography imaging of tumor hypoxia and angiogenesis: imaging biology and guiding therapy -- Noninvasive determination of angiogenesis: molecular targets and tracer development -- Gross tumor volume and clinical target volume: anatomical computed tomography and functional FDG-PET -- Post-treatment changes in tumor microenvironment: dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging -- In vivo molecular imaging in oncology: principles of reporter gene expression imaging -- Medical radiation-induced cancer -- Adrenal lesions: role of computed tomography, magnetic resonance imaging, p18 sF-fluorodeoxyglucose-positron emission tomography, and positron emission tomography/computed tomography -- Hemangioendothelioma: whole-body technetium-99m red blood cell imaging-magnetic resonance imaging -- Malignant bone involvement: assessment using positron emission tomography/computed tomography -- Bone metastasis: single photon emission computed tomography/computed tomography -- Bone cancer: comparison of p18 sF-fluorodeoxyglucose-positron emission tomography with single photon emission computed tomography -- Bone metastasis in endemic nasopharyngeal carcinoma: p18 sF-fluorodeoxyglucose-positron emission tomography -- Colorectal polyps: magnetic resonance colonography -- Early bile duct carcinoma: ultrasound, computed tomography, cholangiography, and magnetic resonance cholangiography -- Incidental extracolonic lesions: computed tomography -- Colorectal cancer: magnetic resonance imaging-cellular and molecular imaging --
505 0 $a Potential new staging perspectives in colorectal cancer: whole-body PET/CT-colonography -- Thoracic esophageal cancer: interstitial magnetic lymphography using superparamagnetic iron -- Esophageal cancer; comparsion of p18 sF-fluoro-3deoxy-3-[L]-fluorothymidine-positron emission tomography with p18 sf-fluorodeoxyglucose-positron emission tomography -- Gastrointestinal stromal tumors: positron emission tomography and contrast-enhanced helical computed tomography -- Gastrointestinal stromal tumor: computed tomography -- Gastrointestinal lipomas: computed tomography -- Computed tomography in peritoneal surface malignancy -- Gastrointestinal tumors: computed tomography/endoscopic ultrasonography -- Magnetic resonance cholangiopancreatography -- Occult primary head and neck carcinoma: role of positron emission tomography imaging -- Benign and malignant nodes in the neck: magnetic resonance microimaging -- Oral squamous cell carcinoma: comparison of computed tomography with magnetic resonance imaging -- Computed tomography in renal cell carcinoma -- Renal cell carcinoma subtypes: multislice computed tomography -- Renal impairment: comparison of noncontrast computed tomography, magnetic resonance urography, and combined abdominal radiography/ultrasonography -- Renal lesions: magnetic resonance diffusion-weighted imaging -- Malignant lymphoma: p18 sF-fluorodeoxyglucose-positron emission tomography -- Malignant melanoma: positron emission tomography -- Multiple myeloma: scintigraphy using technetium-99m-2-methoxyisobutylisonitrile -- Nasopharyngeal carcinoma: p18 sF-fluorodexyglucose-positron emission tomography -- Nasopharyngeal carcinoma for staging and restaging with p18 sF-FDG-PET/CT -- Ovarian sex cord stromal tumors: computed tomography and magnetic resonance imaging -- Malignant germ cell tumors: computed tomography and magnetic resonance imaging -- Ovarian small round cell tumors: magnetic resonance imaging -- Ovarian borderline serous surface papillary tumor: magnetic resonance imaging -- Chronic pancreatics versus pancreatic cancer: positron emission tomography -- Pancreatic cancer: P-[ p123 sl] lodo-L-phenylalanine single photon emission tomography for tumor imaging -- Pancreatic islet cell tumors: endoscopic ultrasonography -- Parotid gland tumors: advanced imaging technologies -- Pituitary macroadenomas: intraoperative magnetic resonance imaging and endonasal endoscopy -- Penile cancer staging: p18 sF-fluorodeoxyglucose-positron emission tomography/computed tomography -- Malignant peripheral nerve sheath tumors: [ p18 sF]fluorodeoxyglucose-positron emission tomography -- Prostate cancer: p11 sC-choline-positron emission tomography -- Metabolic characterization of prostate cancer: magnetic resonance spectroscopy -- Prostate cancer: diffusion-weighted imaging -- Prostatic secretory protein of 94 amino acids, gene-directed transgenic prostate cancer: three-dimensional ultrasound microimaging -- Prostate cancer within the transition zone: gadolinium-enhanced magnetic resonance imaging -- Rectal wall invasion of locally advanced prostate cancer: comparison of magnetic resonance imaging with transrectal ultrasound -- Local staging of prostate cancer using endorectal coil magnetic resonance imaging -- Extremity sarcoma: positron emission tomography -- Retroperitoneal synovial sarcoma: color-doppler ultrasound, computed tomography, and magnetic resonance imaging -- Thymona: computed tomography -- Hemolymphangiomatosis of the spleen: conventional diagnostic imaging and magnetic resonance imaging with superparamagnetic contrast agent -- Thyroid cancer: p18 sF-FDG-positron emission tomography -- Thyroid cancer: p18 sF-fluoro-2-deoxy-D-glucose-positron emission tomography (an overview) -- Diagnosis of thyroid cancer in children: value of power doppler ultrasound.
520 $a With cancer related deaths projected to rise to 10.3 million people by 2020, the need to prevent, diagnose, and cure cancer is greater than ever. These two volumes present readers with the most up-to-date imaging instrumentation, general and diagnostic applications for various cancers. Both volumes discuss the various imaging techniques used to locate and diagnose tumors, including ultrasound, X-ray, color Doppler sonography, PET, CT, PET/CT, MRI, SPECT, diffusion tensor imaging, dynamic infrared imaging, and magnetic resonance spectroscopy. They also detail strategies for imaging cancer, emphasizing the importance of the use of this technology for clinical diagnosis. Imaging techniques that predict the malignant potential of cancers, response to chemotherapy and other treatments, recurrence, and prognosis are also detailed. Both volumes [Volume 1: 978-0-12-370468-9 and Volume 2: 978-0-12-374183-7] are sold separately for $189 each. Concentrates on the application of imaging technology to the diagnosis and prognosis of lung, breast, prostate, colorectal, ovarian, gastrointestinal, and bone cancers Addresses relationship between radiation dose and image quality Discusses the role of molecular imaging in identifying changes for the emergence and progression of cancer at the cellular and/or molecular levels.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2008. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on May 14, 2008). $n Access may be restricted to users at subscribing institutions.
650 0 $a Cancer $x Imaging. $3 403967
650 1 2 $a Diagnostic Imaging $x methods. $3 401803
650 1 2 $a Neoplasms $x diagnosis. $3 403968
650 2 2 $a Breast Neoplasms $x diagnosis. $3 402070
650 2 2 $a Diagnostic Imaging $x instrumentation. $3 403969
650 2 2 $a Lung Neoplasms $x diagnosis. $3 403970
655 7 $a Electronic books. $2 local $3 336502
700 1 $a Hayat, M. A., $d 1940- $3 403966
710 2 $a ScienceDirect (Online service) $3 365609
776 1 $c Original $z 9780123742124 $z 0123742129 $z 9780123704689 $z 0123704685 $z 9780123741837 $z 0123741831 $w (DLC) 2007002969 $w (OCoLC)81252647
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780123742124 $z An electronic book accessible through the World Wide Web; click for information
856 4 1 $3 Table of contents only $u http://www.loc.gov/catdir/toc/ecip079/2007002969.html
994 $a C0 $b TEF